Skip to main content

Cough-Cold and Flu

  • Bayer introduces Walgreens-exclusive saline nasal care line

    WHIPPANY, N.J. — Bayer Consumer Health on Wednesday introduced its hydraSense daily nasal care line exclusively through Walgreens. Company officials say will offer drug-free saline nasal care solutions for infants and children ages 6 months and older.

  • GSK ready to kick the tires of any Pfizer OTC divestiture

    LONDON — If Pfizer follows through with its announcement last week to potentially place its consumer business up for sale, GlaxoSmithKline, presently the third-largest OTC seller in the U.S. marketplace, would certainly take a look at it, the company's CEO shared Wednesday morning.

  • DSNTV: EZC Pak brings immune support from doctor's office to OTC space

    Los Angeles-based EZC Pak has helped physicians reduce the number of antibiotics prescribed during initial visits, and is setting its sights on the consumer health market.
  • Lolleez fills niche sore throat need with kid friendly solution

    WASHINGTON, Conn. — Lolleez on Tuesday announced the launch of a new line of throat soothing lollipops for kids that capitalizes on the current "cleaner ingredient" trend with Certified Organic ingredients and alleviates a risk of choking associated with lozenges and cough drops.

  • To tackle the grime and grit of New York, Olika launches 2-in-1 sanitizer

    NEW YORK – Olika on Thursday announced that Birdie – a two-in-one hand sanitizer containing a spray and dry wipes, has been launched into the New York City market.

    New Yorkers can now re-stock their “flock” of Birdies along with supplements, snacks and personal care products at New York’s iconic grocery store Fairway Market.
     

  • CHPA launches DXM age-restriction resource for retailers

    WASHINGTON — The Consumer Healthcare Products Association on Wednesday announced a new initiative to support retailers in states that have adopted laws prohibiting the sale of over-the-counter medicines containing the cough suppressant dextromethorphan to minors. The announcement comes on the heels of Nevada’s enactment of a DXM age-restriction law last week.

  • ‘For sale’ sign could soon hang over Pfizer’s consumer healthcare business

    NEW YORK — Pfizer on Tuesday might be putting its $3.4 billion consumer healthcare business on the sales block, noting that all scenarios would be considered during a strategic review of its options, which include a full or partial separation of the business from Pfizer through a spin-off, sale or other transaction.

    Of course, Pfizer may ultimately determine to retain the business, the company added.

  • CityMD survey uncovers germiest places during flu season

    NEW YORK — As flu season kicks off and the probability of catching the flu is a real concern, a majority of Americans admit to taking actions that may contribute to the spread of this highly contagious virus.

    According to a new survey, roughly three out of five Americans who have had the flu or flu-like symptoms (61%) admitted to being out and about the last time they felt sick, putting others at risk, likely without them knowing.

X
This ad will auto-close in 10 seconds